Hexindai Inc. Sponsored ADR (HX)
(Delayed Data from NSDQ)
$2.92 USD
+0.07 (2.46%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.92 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Akso Health Group Sponsored ADR [HX]
Reports for Purchase
Showing records 1 - 13 ( 13 total )
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Drop Coverage Of Hexindai Inc (HX), Effective Immediately
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Expect 2Q:F20 Results To Confirm Loan Trough In 1Q:F20, Lower Estimates And Target To $3
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
P2P Market Uncertainty Has Pressured Results, Maintain $4 Target.
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Estimate Sharp EPS Rebound In F2020, But Expect Ongoing Macro-Economic Headwinds In China
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
As Expected, Loan Volume Rebounded In 4Q:F19; Recent Developments Support Our Expectation
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Expect A Sequential Lift In Total Loans Facilitated In 4Q:F19
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Fine-Tune EPS Forecast Through F2021 To Reflect Recent Note Issuance; Contend 3Q:F19 Marked
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Tighter Cost Management Fueled A Narrower Net Loss In 3Q:F19
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Expect 3Q:F19 Marked A Trough In Total Loans Facilitated; View HX As Poised For A Revenue
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Financial - Miscellaneous Services
Re-Initiate Coverage Of Hexindai Inc. (HX) With A $5 Price Target
Provider: SIDOTI CSR
Analyst: Research Department
Company: Akso Health Group Sponsored ADR
Industry: Unclassified
5M 2018 China P2P Industry Review
Provider: JL Warren Capital LLC
Company: Akso Health Group Sponsored ADR
Industry: Unclassified
5M 2018 China P2P Industry Review
Provider: JL Warren Capital LLC
Company: Akso Health Group Sponsored ADR
Industry: Unclassified
4M 2018 China P2P Industry Review - New Loan Origination Down 12% YoY in April Total Loan Balance Down 5%
Provider: JL Warren Capital LLC
|